CaBiDi Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$212K
- Investors
-
1
CaBiDi General Information
Description
Developer of drug delivery technology designed for the establishment of cannabidiol nanoparticles for tumor therapy. The company has developed a novel nanoparticle concept for the transport/release of cannabidiol as a chemotherapeutic natural product, enabling healthcare professionals to make effective drugs.
Contact Information
Corporate Office
- Herrenstrasse 12
- 30159 Hanover
- Germany
Corporate Office
- Herrenstrasse 12
- 30159 Hanover
- Germany
CaBiDi Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2023 | $212K | Completed | Startup |
CaBiDi Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioIntelligence | Accelerator/Incubator |
CaBiDi FAQs
-
When was CaBiDi founded?
CaBiDi was founded in 2022.
-
Where is CaBiDi headquartered?
CaBiDi is headquartered in Hanover, Germany.
-
What industry is CaBiDi in?
CaBiDi’s primary industry is Drug Delivery.
-
Is CaBiDi a private or public company?
CaBiDi is a Private company.
-
What is CaBiDi’s current revenue?
The current revenue for CaBiDi is .
-
How much funding has CaBiDi raised over time?
CaBiDi has raised $212K.
-
Who are CaBiDi’s investors?
BioIntelligence has invested in CaBiDi.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process